Under Keyword - "Pharmaceutical"

[EUREKA/Eurostars2]New drugs applicable on cancer, obese, diabetes, Alzheimer, brain disease, inflammation, and metabolic disease


Date: 12/07/2018

A Korean company, working on the development of treatments for terminal and chronic diseases, is looking for partners to collaborate on EUREKA/Eurostars2 project proposal. The project is related to drugs, biological new medicine (therapeutic proteins, peptides, antibodies, gene treatment, immunology for cancer, immune cell therapy) technology. The company is seeking companies and research institute specialized in the cultivation of New drugs. Read More [EUREKA/Eurostars2]New drugs applicable on cancer, obese, diabetes, Alzheimer, brain disease, inflammation, and metabolic disease

[EUREKA/Eurostars2] Partners to be sought for cooperation in research on comparative study of hypercholesterolemia and atherosclerosis model of Arterial Vessel On-Chip System and animal model


Date: 11/30/2018

A Korean SME, specialized in production of chemical medications with natural products, is seeking for partners to collaborate on EUREKA/Eurostar2 project proposal. The company’s on-going research which is Vessel On-Chip is the purpose of this project. Partners are sought for companies and research institute specialized in production of chemical medications. Read More [EUREKA/Eurostars2] Partners to be sought for cooperation in research on comparative study of hypercholesterolemia and atherosclerosis model of Arterial Vessel On-Chip System and animal model

Pharmaceutical compositions that act as adenosine receptor antagonist which cures liver diseases, such as Nonalcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis of liver containing adenosine d


Date: 11/30/2018

A bio-venture Korean SME has developed first-in-class drug synthesis since established in 2015, and the company represents new drug candidates that have an efficiency of relief on Nonalcoholic Steatohepatitis, Liver Fibrosis, and Liver Cirrhosis, which are called Adenosine Receptor Antagonist. The company came up with the idea due to lack of pharmaceutical treatment for NASH. The company is, thus, open to take the partnership of license and commercial agreement with technical assistant. Read More Pharmaceutical compositions that act as adenosine receptor antagonist which cures liver diseases, such as Nonalcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis of liver containing adenosine d

Highly efficient Drug Delivery System (DDS) for drugs and biocosmeceuticals


Date: 05/21/2018

A Korean bio-venture company has developed a new specific Cell Penetrating Peptide (CPP) - cargo drug delivery system that can be applied to the development of drugs and treatments of wrinkle improvement, autoimmune disease and neurodegenerative diseases based on the technical activity. The company is looking for partners interested in the development of pharmaceuticals or bio-cosmeceuticals to carry out non-clinical and clinical studies under research and technical cooperation agreement. Read More Highly efficient Drug Delivery System (DDS) for drugs and biocosmeceuticals

Restore and heal wounds using amino acid from silk


Date: 06/17/2017

A Korean SME is looking for technology that can be used for recovering wounds with refined amino acid. The company is specialised in manufacturing silk based materials that can be used for bio purposes. The company is open for commercial agreement with technical assistance, license agreement, manufacturing agreement. Read More Restore and heal wounds using amino acid from silk

Opportunity for collaboration in the NEUROIMMUNOLOGY/NEUROINFLAMMATORY area


Date: 12/27/2017

A large Japanese pharmaceutical company is currently seeking for biotech companies and startups to collaborate in the neuroimmunology/neuroinflammatory area. The partnership includes collaborative research/development, out-licensing of asset or technology and possible funding opportunity depending on the term. Read More Opportunity for collaboration in the NEUROIMMUNOLOGY/NEUROINFLAMMATORY area

Opportunity for collaboration in the IMMUNOLOGY area


Date: 08/21/2017

A large pharmaceutical company is currently seeking partner to collaborate in the immunology area. Researches or technologies must have patent applications which have not yet been published. Read More Opportunity for collaboration in the IMMUNOLOGY area

Opportunity for collaboration in the ONCOLOGY area


Date: 08/21/2017

A large pharmaceutical company is currently seeking partner to collaborate in the oncology area. Researches or technologies must have patent applications which have not yet been published. Read More Opportunity for collaboration in the ONCOLOGY area

Eurostars2: Partners sought to cooperate in research on protein drugs to prevent and/or treat bone destruction


Date: 06/19/2017

A Korean SME, a research-oriented venture enterprise, is looking for partners to collaborate in a Eurostars2 project proposal. The project aims to develop protein or chemical compound drugs and health functional foods to prevent and treat bone destruction caused by bone metastasis from breast carcinoma or osteoporosis. The SME is seeking companies, universities, or research institutes specialized in breast cancer and protein engineering. Read More Eurostars2: Partners sought to cooperate in research on protein drugs to prevent and/or treat bone destruction

Novel pharmaceutical composition for anaplastic thyroid carcinoma


Date: 06/15/2017

A Korean company specialised in biomedical science has developed a new treatment for anaplastic thyroid carcinoma. The new pharmaceutical composition will enable to cure undifferentiated thyroid cancer. The company is looking for partners to make license agreement with or progress joint research and development. Read More Novel pharmaceutical composition for anaplastic thyroid carcinoma

EUROSTARS: An effective new medicine for treatment of atopy root cause


Date: 06/13/2017

A South Korean SME specialized in developing a new medicine and companion diagnostics has developed a medicine to treat atopy. They are currently looking for companies in expertise of medical trial to co-develop this integrated system in the context of a EUROSTARS project.  Read More EUROSTARS: An effective new medicine for treatment of atopy root cause

Artificial intelligence (AI) and Deep learning technology in drug discovery


Date: 02/18/2017

A large pharmaceutical company is now seeking for opportunity for collaboration. Request for Technology: Researchers, research projects in universities/institutes and startups, which have earlystage technology, research or services of Artificial intelligence (AI), deep learning in the field of drug discovery and pharmaceutical research. Technology/research should preferably be related with chemistry-related matter such as medicinal chemistry, organic synthesis and safety assessment/prediction of drug candidates. Researcher/research institute/startups, who explore application of their technology in the future drug discovery project of pharmaceutical industry, are highly desirable. Read More Artificial intelligence (AI) and Deep learning technology in drug discovery

    Inquiry Contact

    Contact below with your service requirements

    Ms. Su Wan Cho
    +82-2-3278-2706
    suwancho93@dtk3.com

    Industries

    Technology Requests or Offers?